Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,984,655
+$2,009,643 QoQ
Shares Held
6,007,455
+3.1% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ARDX ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ARDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,984,655 | 6,007,455 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,975,012 | 5,827,618 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $31,719,890 | 5,756,786 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $22,211,064 | 5,666,088 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $27,852,509 | 5,672,609 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $27,934,330 | 5,509,730 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $37,810,542 | 5,487,742 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $40,536,004 | 5,470,446 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $38,024,305 | 5,208,809 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $30,971,244 | 4,995,362 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $18,186,322 | 4,457,432 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,292,802 | 4,216,166 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,475,448 | 1,978,173 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,921,770 | 1,726,937 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,711,537 | 1,438,267 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $535,918 | 908,336 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,787,273 | 1,670,349 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,500,363 | 1,363,967 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,334,166 | 1,768,308 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,948,536 | 1,444,398 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,508,831 | 1,285,322 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,512,627 | 1,161,148 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,929,239 | 1,129,379 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,650,322 | 1,105,538 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,721,503 | 1,006,421 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||